These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 25658710

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB, Johnson JS, Angeles JE, Behling C, Belt PH, Borecki I, Bross C, Durelle J, Goyal NP, Hamilton G, Holtz ML, Lavine JE, Mitreva M, Newton KP, Pan A, Simpson PM, Sirlin CB, Sodergren E, Tyagi R, Yates KP, Weinstock GM, Salzman NH.
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [Abstract] [Full Text] [Related]

  • 23. Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients.
    Hendriks HJ, van Kreel B, Forget PP.
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):260-5. PubMed ID: 11593119
    [Abstract] [Full Text] [Related]

  • 24. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study.
    Leung DH, Ye W, Schwarzenberg SJ, Freeman AJ, Palermo JJ, Weymann A, Alonso EM, Karnsakul WW, Murray KF, Stoll JM, Huang S, Karmazyn B, Masand P, Magee JC, Alazraki AL, Towbin AJ, Nicholas JL, Green N, Otto RK, Siegel MJ, Ling SC, Navarro OM, Harned RK, Narkewicz MR, Molleston JP, CFLD Research Network.
    J Cyst Fibros; 2023 Mar; 22(2):248-255. PubMed ID: 35985930
    [Abstract] [Full Text] [Related]

  • 25. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis.
    van Elburg RM, Uil JJ, van Aalderen WM, Mulder CJ, Heymans HS.
    Pediatr Res; 1996 Jun; 39(6):985-91. PubMed ID: 8725259
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evidence for a Cystic Fibrosis Enteropathy.
    Adriaanse MP, van der Sande LJ, van den Neucker AM, Menheere PP, Dompeling E, Buurman WA, Vreugdenhil AC.
    PLoS One; 2015 Jun; 10(10):e0138062. PubMed ID: 26484665
    [Abstract] [Full Text] [Related]

  • 30. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.
    Hawkey CJ, Ell C, Simon B, Albert J, Keuchel M, McAlindon M, Fortun P, Schumann S, Bolten W, Shonde A, Hugot JL, Yu V, Arulmani U, Krammer G, Rebuli R, Toth E.
    Clin Gastroenterol Hepatol; 2008 May; 6(5):536-44. PubMed ID: 18242145
    [Abstract] [Full Text] [Related]

  • 31. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
    Sipponen T, Haapamäki J, Savilahti E, Alfthan H, Hämäläinen E, Rautiainen H, Koskenpato J, Nuutinen H, Färkkilä M.
    Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    Chinese Experts Cystic Fibrosis Consensus Committee, Chinese Alliance for Rare Lung Diseases, Chinese Alliance for Rare Diseases, Bronchiectasis-China.
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr 12; 46(4):352-372. PubMed ID: 36990700
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
    Kristensen M, Prevaes SMPJ, Kalkman G, Tramper-Stranders GA, Hasrat R, de Winter-de Groot KM, Janssens HM, Tiddens HA, van Westreenen M, Sanders EAM, Arets B, Keijser B, van der Ent CK, Bogaert D.
    J Cyst Fibros; 2020 Jul 12; 19(4):553-561. PubMed ID: 32487494
    [Abstract] [Full Text] [Related]

  • 36. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M, Simms LA, Brown A, Appleyard M, Irwin J, Waddell N, Radford-Smith GL.
    J Crohns Colitis; 2019 Mar 30; 13(4):451-461. PubMed ID: 30445599
    [Abstract] [Full Text] [Related]

  • 37. Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.
    Vogt A, Reuken PA, Stengel S, Stallmach A, Bruns T.
    World J Gastroenterol; 2016 Mar 21; 22(11):3275-84. PubMed ID: 27004006
    [Abstract] [Full Text] [Related]

  • 38. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
    Melmed GY, Dubinsky MC, Rubin DT, Fleisher M, Pasha SF, Sakuraba A, Tiongco F, Shafran I, Fernandez-Urien I, Rosa B, Papageorgiou NP, Leighton JA.
    Gastrointest Endosc; 2018 Dec 21; 88(6):947-955.e2. PubMed ID: 30086261
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Elevated fecal calprotectin levels are associated with severity of atopic dermatitis in children.
    Seo SC, Ahn SH, Ri S, Yoon Y, Byeon JH, Kim SH, Yoon W, Yoo Y.
    Asian Pac J Allergy Immunol; 2018 Jun 21; 36(2):82-87. PubMed ID: 28938841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.